Insights from Digital Pharma Leaders
Refine Search
Pharmaceutical
Google and other search engines are putting consumers at risk of buying fake pharmaceutical products by refusing to remove these websites in their search results. 22 October 2019
Pharmaceutical
China is currently the second largest pharmaceutical market in the world and is aiming to be a major innovator as well, as part of its ‘Made in China 2025’ program. 14 October 2019
Pharmaceutical
Germany’s Bayer has opened LifeHub UK, the latest in a series of innovation hubs focused on artificial intelligence. 10 October 2019
Biotechnology
Hong Kong-based Insilico Medicine, a company developing an end-to-end drug discovery pipeline utilizing the latest advances in deep learning, has entered into a two-program AI drug discovery collaboration agreement with Jiangsu Chia Tai Fenghai Pharmaceutical (CTFH), taking on previously undruggable targets. 9 October 2019
Biotechnology
A new research collaboration between Danish diabetes giant Novo Nordisk and the Cambridge, USA-based firm bluebird bio will see the companies work together on certain in vivo gene editing technologies. 9 October 2019
Pharmaceutical
Swiss pharma giant Novartis has launched a new digital collaboration with Microsoft, a software company, aimed at boosting the firm’s artificial intelligence capabilities. 1 October 2019
Pharmaceutical
BenevolentAI, a UK artificial intelligence (AI) company focused on health and drug development, has announced a new collaboration, with Swiss giant Novartis. 6 September 2019
Pharmaceutical
Pharma and other health companies are buying big into the artificial intelligence (AI) space, and the UK’s Health Secretary has now given this technology a major vote of confidence too. 8 August 2019
Biotechnology
A company that calls itself the world-leading AI-driven drug discovery company has entered into a collaboration with Rallybio, a privately-held development-stage biotechnology company focused on rare diseases. 23 July 2019
Pharmaceutical
IBM Watson Health has seen that being thought of as a pioneering company in applying artificial intelligence (AI) in healthcare can have its pros and cons, from a publicity point of view. 2 July 2019
Pharmaceutical
French pharma major Sanofi has gone big in its latest effort to address the perennial problem of how to speed up medical innovation. 18 June 2019
Pharmaceutical
Merck & Co is to participate in a US Food and Drug Administration (FDA) pilot program that uses blockchain technology to improve the way medicines are identified, tracked and traced within the USA. 13 June 2019
Pharmaceutical
The life sciences arm of Google-parent company Alphabet, Verily, has announced that four of the world’s leading pharma companies have joined its Project Baseline initiative. 22 May 2019
Pharmaceutical
In a previous incarnation, Boehringer Ingelheim chief financial officer Michael Schmelmer spearheaded a bold approach to innovation which could bear digital fruit for the 130 year-old family-owned drugmaker. 10 May 2019
Pharmaceutical
Japanese firms Eisai and Allm have agreed terms for a capital and business alliance agreement related to ICT digital health solutions and regional medical treatment and care. 9 May 2019
Pharmaceutical
The pharmaceutical industry is adopting artificial intelligence (AI) on numerous fronts, from discovery and clinical development to risk assessment and safety monitoring, regulatory, and manufacturing. 8 May 2019
Pharmaceutical
As pivotal changes in healthcare and drug development gain traction, new analysis from management consultancy Arthur D Little (ADL) highlights that all sectors of the industry must evolve their business and operating models in the coming decade. 2 May 2019
Pharmaceutical
At its annual general meeting in Frankfurt, Merck KGaA outlined plans to secure future growth, including ambitious goals in the contract manufacturing sector, and in digital technologies. 26 April 2019
Pharmaceutical
In an Expert View piece, Oliver Kidd, senior associate at Stevens & Bolton, provides an overview of an ever-more complex landscape. 24 April 2019
Pharmaceutical
South Korea CNS medicines specialist SK Biopharmaceuticals and twoXAR, a US artificial intelligence (AI)-driven biopharmaceutical company, today announced an agreement to discover and develop first-in-class therapeutics for non-small cell lung cancer (NSCLC). 18 April 2019
Pharmaceutical
Precision medicine has advanced significantly over the past decade, driven by breakthroughs in chemical, hardware, software, and especially cloud computing technologies. 18 March 2025
Biotechnology
MeiraGTx has entered into a strategic partnership with artificial intelligence firm Hologen to accelerate the Phase III development of AAV-GAD, a gene therapy for Parkinson’s disease. 13 March 2025
Pharmaceutical
Insilico Medicine has raised $110 million in a series E funding round to drive the development of its artificial intelligence-powered drug candidates, including its leading drug for idiopathic pulmonary fibrosis (IPF). 13 March 2025
Pharmaceutical
Germany’s Boehringer Ingelheim has launched the One Medicine Platform, a new system designed to streamline drug development, following the implementation of Veeva Systems' Development Cloud. 12 March 2025
Biotechnology
Nona Biosciences has introduced Hu-mAtrIx, an AI-assisted drug discovery platform designed to accelerate the identification and development of antibody-based therapies. 7 March 2025
Pharmaceutical
The new US President has repealed an executive order from October 2023, signed by the Biden administration, that sought to establish rigorous safeguards for artificial intelligence (AI) development. 22 February 2025
Pharmaceutical
US biopharma Incyte and privately-held AI-focused biotech Genesis Therapeutics have entered into a strategic collaboration focused on the research, discovery and development of novel small molecule medicines. 21 February 2025
Pharmaceutical
An Expert View from Kevin Wild, head of pre-sales at software company Syniti. 23 January 2025
Pharmaceutical
French pharmaceutical company Servier and Google Cloud have announced an expanded five-year partnership aimed at leveraging artificial intelligence (AI) and generative AI to accelerate drug research and development. 16 January 2025
Pharmaceutical
A collection of some of the largest US health systems, in collaboration with the Regeneron Genetics Center, have announced the launch of the Truveta Genome Project. 16 January 2025
Pharmaceutical
Privately-held Italian drugmaker Menarini and its oncology-focused subsidiary Stemline Therapeutics have entered into a licensing deal with AI-driven biotech Insilico Medicines. 15 January 2025
Biotechnology
Dyno Therapeutics, a privately-held US genetic technologies company applying AI to enable in vivo gene delivery, has announced that Roche has exercised its option to license a novel capsid for use in a gene therapy program for an undisclosed neurological disease indication. 13 January 2025
Pharmaceutical
Real-world evidence (RWE) specialist Atropos Health has announced a collaboration with US pharma giant Merck & Co. 13 January 2025
Biotechnology
Belgian biopharmaceutical company UCB has entered into a license agreement with Ailux Biologics, the biologics discovery division of XtalPi, to leverage its AI platform. 9 January 2025
Pharmaceutical
Insilico Medicine, a biotechnology firm specializing in artificial intelligence-powered drug discovery, has raised over $100 million in a series E funding round. 8 January 2025
Pharmaceutical
A team of Chinese researchers has identified a promising candidate for glaucoma treatment using artificial intelligence tools. 6 January 2025
Pharmaceutical
The market for artificial intelligence (AI) in cancer care is projected to grow from $2.2 billion in 2024 to $6.3 billion by 2029, reflecting a growth rate of 23.1%, according to a recent study by BCC Research. 31 December 2024
Biotechnology
AI-driven biotech BenevolentAI has announced sweeping changes aimed at refocusing its operations and extending its financial runway into 2027. 20 December 2024
Pharmaceutical
Shanghai-based Fangzhou, has entered into a strategic partnership with the Chinese business of Bristol Myers Squibb China, with the goal of enhancing digital platforms for chronic disease management. 19 December 2024
Pharmaceutical
Swedish biotech company Inify Laboratories has raised approximately 135 million kroner ($12.3 million) through a private placement, supporting a planned expansion into the UK. 16 December 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze